These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3096289)

  • 1. [Advantages of ambulatory nutritional therapy from the viewpoint of health insurance].
    Leopold D
    Beitr Infusionther Klin Ernahr; 1986; 14():196-201. PubMed ID: 3096289
    [No Abstract]   [Full Text] [Related]  

  • 2. [Legal aspects of ambulatory nutritional therapy].
    Morgenstern E
    Beitr Infusionther Klin Ernahr; 1986; 14():202-8. PubMed ID: 3096290
    [No Abstract]   [Full Text] [Related]  

  • 3. Home chemotherapy: problems, pitfalls, considerations, and solutions.
    Joseph R; Dolby P; Forrest J
    Prog Clin Biol Res; 1986; 216():165-74. PubMed ID: 3523531
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ambulatory nutrition procedures from the viewpoint of the health office].
    Bokelmann M
    Z Gastroenterol; 1989 Jun; 27 Suppl 2():58-60. PubMed ID: 2514510
    [No Abstract]   [Full Text] [Related]  

  • 5. A physician's perspective on the advantages of home medical care: the other side of case management.
    Hart JS; Redding KL
    Tex Med; 1994 Feb; 90(2):50-4. PubMed ID: 8165587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of health insurance.
    Gerber CH; Shively DL
    Ohio State Med J; 1979 May; 75(5):320-3. PubMed ID: 111199
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ambulatory nutrition results from the viewpoint of health insurance].
    Danisch G
    Krankenpfl J; 1989 Jun; 27(6):84-6. PubMed ID: 2502669
    [No Abstract]   [Full Text] [Related]  

  • 8. Current reimbursement and regulatory issues for nutrition support services.
    MacKinnon SA
    Caring; 1984 Nov; 3(11):58-60. PubMed ID: 10310882
    [No Abstract]   [Full Text] [Related]  

  • 9. Third-party reimbursement for home parenteral nutrition and I.V. therapy.
    Curtiss FR
    NITA; 1983; 6(3):193-7. PubMed ID: 6412180
    [No Abstract]   [Full Text] [Related]  

  • 10. [A decision by the Swiss insurance court: instead of home nursing rates compensation for work according to the tariff].
    Reinhart R
    Krankenpfl Soins Infirm; 1986 Aug; 79(8):72-3. PubMed ID: 3638420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Home nursing of demented patients as an economic factor in public health].
    Hallauer J
    Krankenpfl J; 2004; 42(3-4):109-10. PubMed ID: 15311906
    [No Abstract]   [Full Text] [Related]  

  • 12. Saving money with home care.
    Schoumacher RA
    Am J Dis Child; 1991 Jul; 145(7):725. PubMed ID: 2058601
    [No Abstract]   [Full Text] [Related]  

  • 13. How home hyperalimentation thru the health team saves $ for patients compared to hospital therapy.
    Knutsen C
    Pharm Times; 1985 Aug; 51(8):84-9. PubMed ID: 10311218
    [No Abstract]   [Full Text] [Related]  

  • 14. Parenteral nutrition in different settings. Results of an economic study.
    Dinkel R
    Int J Technol Assess Health Care; 1985; 1(2):335-41. PubMed ID: 10311547
    [No Abstract]   [Full Text] [Related]  

  • 15. [Home care of AIDS patients from the medical and nursing viewpoint--a project in Vienna].
    Armbruster C; Vetter N
    Acta Med Austriaca; 1994; 21(1):14-6. PubMed ID: 8017162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third-party payers create snags for home IV antibiotic programs.
    Hosp Peer Rev; 1983 May; 8(5):60-2. PubMed ID: 10309993
    [No Abstract]   [Full Text] [Related]  

  • 17. [Controlling ambulatory medical care by remunerative procedures?].
    Düttmann R
    ZFA (Stuttgart); 1983 Jul; 59(21):1165-9. PubMed ID: 6636988
    [No Abstract]   [Full Text] [Related]  

  • 18. Does the primary-care gatekeeper control the costs of health care? Lessons from the SAFECO experience.
    Moore SH; Martin DP; Richardson WC
    N Engl J Med; 1983 Dec; 309(22):1400-4. PubMed ID: 6633615
    [No Abstract]   [Full Text] [Related]  

  • 19. [Health insurance agencies have 9.5 billion marks on the high edge].
    von Samson E
    Pflege Z; 1999 Nov; 52(11):770-1. PubMed ID: 10788928
    [No Abstract]   [Full Text] [Related]  

  • 20. Suppliers win reversal on PEN reimbursement.
    Beck E
    Med Prod Sales; 1985 Jan; 16(1):53, 64. PubMed ID: 10310962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.